| EDGE Market Cap History Table | ||||||||||||||||||||||||||||||||
Below is a table of the EDGE market cap history going back to 10/1/2015:
Also see: EDGE Shares Outstanding History and EDGE YTD Return |
As of 2/14/2019 Edge Therapeutics has a market cap of 12.60 million. Investors often follow the EDGE market cap history to compare the size of the company over time.
This page shows EDGE market capitalization trends over time, with 15 market cap datapoints presented, dating back to 10/1/2015.

| EDGE Market Cap History Table | ||||||||||||||||||||||||||||||||
Below is a table of the EDGE market cap history going back to 10/1/2015:
Also see: EDGE Shares Outstanding History and EDGE YTD Return |
| EDGE Market Cap History Chart | |||||||||||||||||||||||||||||||||
EDGE Historical Market Cap: -62.14% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||
| EDGE Stock Price Chart |
| About PDS Biotechnology Corp |
| Edge Therapeutics is a clinical-stage biotechnology company that discovers and develops hospital-based therapies for the management of acute, critical care conditions. Co.'s initial product candidates target rare, acute, neurological and other conditions. EG-1962, Co.'s product candidate, is for the management of aneurysmal subarachnoid hemorrhage, which is bleeding around the brain due to a ruptured brain aneurysm. In addition to EG-1962, Co. is developing EG-1964, as a prophylactic treatment in the management of chronic subdural hematoma, to prevent recurrent bleeding on the surface of the brain. Co. is also developing EG-1965, for the prevention of post-operative atrial fibrillation. We show 15 historical shares outstanding datapoints in our EDGE shares outstanding history coverage, used to compute EDGE market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing EDGE market cap history over the course of time is important for investors interested in comparing EDGE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of EDGE versus a peer is one thing; comparing EDGE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like EDGE can fluctuate over the course of history. With this page we aim to empower investors researching EDGE by allowing them to research the EDGE market cap history. |
| EDGE Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| EDGE Share Performance |
| Market Cap Peers |
| Edge Therapeutics (EDGE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
EDIT Market Cap History EGLT Market Cap History EGRX Market Cap History EHAB Market Cap History EHC Market Cap History EIDX Market Cap History EIGR Market Cap History EKSO Market Cap History ELAB Market Cap History ELAN Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.